ARPO - Aerpio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Aerpio Pharmaceuticals, Inc.

9987 Carver Road
Suite 420
Cincinnati, OH 45242
United States
513-985-1920
http://www.aerpio.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees27

Key Executives

NameTitlePayExercisedYear Born
Dr. Stephen J. HoffmanCEO & Director776.57kN/A1954
Dr. Joseph H. GardnerFounder, Pres & Director677.57kN/A1956
Mr. Michael W. RogersChief Financial & Bus. Officer and Principal Financial & Accounting Officer570.7kN/A1960
Mr. Kevin G. PetersChief Scientific Officer & Acting Chief Medical OfficerN/AN/A1957
Dr. Dhaval DesaiChief Strategy OfficerN/AN/A1977
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2b clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio.

Corporate Governance

Aerpio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.